[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Wall St Engine [@wallstengine](/creator/twitter/wallstengine) on x 71.5K followers Created: 2025-07-09 10:09:53 UTC Wells Fargo Raises $MBLY PT to $XX from $18, Maintains Overweight Rating Analyst comments: "Intel Share Sale: MBLY announced that Intel is commencing a secondary offering of 45M MBLY Class A shares (~$840M at 7/8 closing price) + add'l 6.75M 30-day option. Intel is also planning to voluntarily convert an add'l 50M Class B shares into Class A (1:1), but notes it intends to hold these shares at this time and the sole purpose of the conversion is to increase the number of Class A shares issued and outstanding. Exiting 1Q25, Intel held 711.5M Class B shares (87.6% s/o; XXXX% voting right). That said, we expect investors to focus on the potential for Intel to unwind its position further at a future date. In conjunction with the secondary offering, MBLY has agreed to purchase $100M of Class A common stock at a price per share equal to the price to be paid by the underwriters in the offering (note: equates to ~5.36M shares at 7/8 closing price). Positive 2Q25 Preannouncement: MBLY now expects 2Q25 rev / EBIT at $502-$506M (+14%-15% y/y) / $98-$104M (20%-21%; +24%-32% y/y) vs. initial 2Q25 revenue guide at +7% y/y ($470M) and our $469M / $76M est (street @ $466.1M / $69.3M). MBLY has not updated its full CY25 guide; company previously guiding CY25 rev / EBIT guide at $1.69-$1.81B / $175-$260M. Increase Estimates: We increase our 2Q25 rev / EBIT / EPS est. to $503M / $102M / $0.12; move CY25, CY26, and CY27 to $1.84B / $276M / $0.34, $2.14B / $411M / $0.48, and $3.04B / $753M / $0.79, respectively. We note that our updated 2H25 estimates now appear quite conservative; however, we would like to hear more about the drivers of MBLY's 2Q25 upside and demand durability / customer expansion into 2H25. We increase our PT to $XX (was $18) on 24x CY27 EV/EBIT. TSMC Supply Agreement: MBLY has also announced that it has entered into a long-term supply agreement with TSMC for the manufacturing of the company's internal imaging radar and 'some' of its future generations of EyeQ SoCs - diversifying from its long-standing relationship with STMicroelectronics for EyeQ products." Analyst: Aaron Ryker XXXXX engagements  **Related Topics** [$840m](/topic/$840m) [stocks](/topic/stocks) [$wfc](/topic/$wfc) [stocks financial services](/topic/stocks-financial-services) [stocks banks](/topic/stocks-banks) [$mbly](/topic/$mbly) [Post Link](https://x.com/wallstengine/status/1942888932376825949)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Wall St Engine @wallstengine on x 71.5K followers
Created: 2025-07-09 10:09:53 UTC
Wells Fargo Raises $MBLY PT to $XX from $18, Maintains Overweight Rating
Analyst comments: "Intel Share Sale: MBLY announced that Intel is commencing a secondary offering of 45M MBLY Class A shares (~$840M at 7/8 closing price) + add'l 6.75M 30-day option. Intel is also planning to voluntarily convert an add'l 50M Class B shares into Class A (1:1), but notes it intends to hold these shares at this time and the sole purpose of the conversion is to increase the number of Class A shares issued and outstanding. Exiting 1Q25, Intel held 711.5M Class B shares (87.6% s/o; XXXX% voting right). That said, we expect investors to focus on the potential for Intel to unwind its position further at a future date.
In conjunction with the secondary offering, MBLY has agreed to purchase $100M of Class A common stock at a price per share equal to the price to be paid by the underwriters in the offering (note: equates to ~5.36M shares at 7/8 closing price).
Positive 2Q25 Preannouncement: MBLY now expects 2Q25 rev / EBIT at $502-$506M (+14%-15% y/y) / $98-$104M (20%-21%; +24%-32% y/y) vs. initial 2Q25 revenue guide at +7% y/y ($470M) and our $469M / $76M est (street @ $466.1M / $69.3M). MBLY has not updated its full CY25 guide; company previously guiding CY25 rev / EBIT guide at $1.69-$1.81B / $175-$260M.
Increase Estimates: We increase our 2Q25 rev / EBIT / EPS est. to $503M / $102M / $0.12; move CY25, CY26, and CY27 to $1.84B / $276M / $0.34, $2.14B / $411M / $0.48, and $3.04B / $753M / $0.79, respectively. We note that our updated 2H25 estimates now appear quite conservative; however, we would like to hear more about the drivers of MBLY's 2Q25 upside and demand durability / customer expansion into 2H25.
We increase our PT to $XX (was $18) on 24x CY27 EV/EBIT.
TSMC Supply Agreement: MBLY has also announced that it has entered into a long-term supply agreement with TSMC for the manufacturing of the company's internal imaging radar and 'some' of its future generations of EyeQ SoCs - diversifying from its long-standing relationship with STMicroelectronics for EyeQ products."
Analyst: Aaron Ryker
XXXXX engagements
Related Topics $840m stocks $wfc stocks financial services stocks banks $mbly